Mechanistically, corticosteroids could inhibit the nuclear factor kappa B (NF-κB) activation and the extensive inflammatory factors release, finally improving the inflammatory response of sepsis or pneumonia. The gene discussed is NFKB1; the disease is susceptibility to pneumonia measurement.